MPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer

Expert Opinion on Drug Delivery

Volumn 12, Issue 3, 2015, Pages 361-373

  Wang, Shengpeng ^a   Chen, Ruie ^a   Morott, Joe ^b   Repka, Michael A ^b   Wang, Yitao ^a   Chen, Meiwan ^a  

^a University of Macau   (Macao)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Breast cancer resistance; Mixed micelles; MPEG b PCL; Resveratrol; Tocopherol polyethylene glycol succinate

Indexed keywords

ALPHA TOCOPHEROL; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; MACROGOL; MULTIDRUG RESISTANCE PROTEIN; RESVERATROL; SUCCINIC ACID; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; ANTINEOPLASTIC AGENT; DRUG CARRIER; MACROGOL DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL-CO-EPSILON-CAPROLACTONE); MICELLE; POLYESTER; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE G1 PHASE; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DOWN REGULATION; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG UPTAKE; HUMAN; HUMAN CELL; MICELLE; NANOENCAPSULATION; PARTICLE SIZE; PROPIDIUM IODIDE ASSAY; PROTEIN EXPRESSION; RETICULOENDOTHELIAL SYSTEM; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; BREAST NEOPLASMS; CHEMISTRY; DRUG EFFECTS; DRUG TOLERANCE; MEDICINAL CHEMISTRY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG TOLERANCE; HUMANS; MICELLES; P-GLYCOPROTEIN; POLYESTERS; POLYETHYLENE GLYCOLS; STILBENES; VITAMIN E;

EID: 84923332888     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.951634     Document Type: Article

References (44)

1. Gangopadhyay S, Nandy A, Hor P, Mukhopadhyay A. Breast cancer stem cells: a novel therapeutic target. Clin Breast Cancer 2013;13(1):7-15
2. Grassilli E, Narloch R, Federzoni E, et al. Inhibition of GSK3B bypass drug resistance of p53-Null colon carcinomas by enabling necroptosis in response to chemotherapy. Clin Cancer Res 2013;19(14):3820-31
3. Wang Z, Li Y, Ahmad A, et al. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat 2010;13(4-5):109-18
4. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002;53:615-27
5. Huang CY, Chen JY, Wu JE, et al. Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells. J Agric Food Chem 2010;58(15):8798-805
6. Cichewicz RH, Kouzi SA. Resveratrol oligomers: structure, chemistry, and biological activity. Stud Nat Prod Chem 2002;26:507-79
7. Hu Y, Wang S, Wu X, et al. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. J Ethnopharmacol 2013;149(3):601-12
8. Gupta SC, Kannappan R, Reuter S, et al. Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 2011;1215:150-60
9. Vidavalur R, Otani H, Singal PK, Maulik N. Significance of wine and resveratrol in cardiovascular disease: french paradox revisited. Exp Clin Cardiol 2006;11(3):217-25
10. Brown VA, Patel KR, Viskaduraki M, et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 2010;70(22):9003-11
11. Subramanian L, Youssef S, Bhattacharya S, et al. Resveratrol: challenges in translation to the clinic-A critical discussion. Clin Cancer Res 2010;16(24):5942-8
12. Gulcin I. Antioxidant properties of resveratrol: a structure-Activity insight. Innov Food Sci Emerg Technol 2010;11(1):210-18
13. Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA. Resveratrol and related stilbenes: their anti-Aging and anti-Angiogenic properties. Food Chem Toxicol 2013;61:112-20
14. Harikumar KB, Aggarwal BB. Resveratrol: a multitargeted agent for age-Associated chronic diseases. Cell Cycle 2008;7(8):1020-35
15. Das S, Chaudhury A. Pharmacological activities, pharmacokinetics and delivery approaches. In: Delmas D, editor. Resveratrol: sources, production and health benefits. Nova Science Publishers, New York, USA; 2013. p. 465-89
16. Santos AC, Veiga F, Ribeiro AJ. New delivery systems to improve the bioavailability of resveratrol. Expert Opin Drug Deliv 2011;8(8):973-90
17. Shao J, Li X, Lu X, et al. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 2009;72(1):40-7
18. Figueiro F, Bernardi A, Frozza RL, et al. Resveratrol-loaded lipid-core nanocapsules treatment reduces in vitro and in vivo glioma growth. J Biomed Nanotechnol 2013;9(3):516-26
19. Chen Y, Zhang W, Gu J, et al. Enhanced antitumor efficacy by methotrexate conjugated Pluronic mixed micelles against KBv multidrug resistant cancer. Int J Pharm 2013;452(1-2):421-33
20. Zhou S, Deng X, Yang H. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials 2003;24(20):3563-70
21. Guo YY, Luo J, Tan SW, et al. The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci 2013;49(2):175-86
22. Gill KK, Kaddoumi A, Nazzal S. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. Eur J Pharm Sci 2012;46(1-2):64-71
23. Neophytou CM, Constantinou C, Papageorgis P, Constantinou AI. D-Alpha-Tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivinoverexpressing breast cancer cells. Biochem Pharmacol 2014;89(1):31-42
24. Batist G, Tulpule A, Sinha BK, et al. Overexpression of a novel anionic glutathione transferase in multidrugresistant human breast cancer cells. J Biol Chem 1986;261(33):15544-9
25. Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/ formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48(17):4827-33
26. Gao JL, He TC, Li YB, Wang YT. A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-Tumor activity. Oncol Rep 2009;22(5):1077-83
27. Wang S, Zhong Z, Wan J, et al. Oridonin induces apoptosis, inhibits migration and invasion on highlymetastatic human breast cancer cells. Am J Chin Med 2013;41(1):177-96
28. Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010;385(1-2):113-42
29. Yin HQ, Lee ES, Kim D, et al. Physicochemical characteristics of pHsensitive poly(L-Histidine)-b-poly (ethylene glycol)/poly(L-Lactide)-b-poly (ethylene glycol) mixed micelles. J Control Release 2008;126(2):130-8
30. Gokce EH, Korkmaz E, Dellera E, et al. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int J Nanomedicine 2012;7:1841-50
31. Khonkarn R, Mankhetkorn S, Talelli M, et al. Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells. Colloids Surf B Biointerfaces 2012;94:266-73
32. Zhang ZP, Tan SW, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 2012;33(19):4889-906
33. Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev 2008;34(7):592-602
34. Xiao L, Xiong X, Sun X, et al. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 2011;32(22):5148-57
35. Huang C, Lee SY, Lin CL, et al. Co-Treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-beta-d-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 Cells. J Agric Food Chem 2013;61(26):6430-45
36. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35(4):495-516
37. Lou H, Gao L, Wei X, et al. Oridonin nanosuspension enhances anti-Tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids Surf B Biointerfaces 2011;87(2):319-25
38. Wang S, Chen T, Chen R, et al. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Int J Pharm 2012;430(1-2):238-46
39. Wang WZ, Cheng J, Luo J, Zhuang SM. Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis. FEBS Lett 2008;582(18):2689-95
40. Luo H, Su H, Wang X, et al. N-Succinyl-chitosan nanoparticles induced mitochondria-dependent apoptosis in K562. Mol Cell Probes 2012;26(4):164-9
41. LEcuyer T, Sanjeev S, Thomas R, et al. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am J Physiol Heart Circ Physiol 2006;291(3):H1273-H80
42. Kim TH, Shin YJ, Won AJ, et al. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin. Biochim Biophys Acta 2014;1840(1):615-25
43. Choi BH, Kim CG, Lim Y, et al. Curcumin down-regulates the multidrugresistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett 2008;259(1):111-18
44. Zhao H, Yung LY. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. J Biomed Mater Res A 2009;91(2):505-18